Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract

Journal of Traditional and Complementary Medicine

Volumn 7, Issue 3, 2017, Pages 273-280

  Mestry, Snehal Nitin ^a   Dhodi, Jayesh Bachu ^a   Kumbhar, Sangita Balbhim ^a   Juvekar, Archana Ramesh ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Antihyperglycemic; Antioxidant; Diabetic nephropathy; Punica granatum; Streptozotocin

Indexed keywords

EID: 85002893983     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/j.jtcme.2016.06.008     Document Type: Article

References (33)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care 31 (2008), S55–S60, 10.2337/dc08-S055.
2. Makita, Z., Radoff, S., Rayfield, E.J., et al. Advanced glycolsylation end products in patients with diabetic nephropathy. N Engl J Med 325 (1991), 836–842.
3. Yamamoto, T., Nakamura, T., Noble, N.A., Ruoslahti, E., Border, W.A., Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U. S. A 90 (1993), 1814–1818.
4. Schena, F.P., Gesualdo, L., Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16 (2005), S30–S33.
5. Tanios, B.Y., Ziyadeh, F.N., Emerging therapies for diabetic nephropathy patients: beyond blockade of the renin-angiotensin system. Nephron Extra 2 (2012), 278–282.
6. Forbes, J.M., Coughlan, M.T., Cooper, M.E., Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57 (2008), 1446–1454.
7. Horie, K., Miyata, T., Maeda, K., et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 100 (1997), 2995–3004.
8. Lewis, E.J., Hunsicker, L.G., Bain, R.P., Rohde, R.D., The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med 329 (1993), 1456–1462.
9. Garachh, D., Patel, A., Chakraborty, M., Kamath, J.V., Phytochemical and pharmacological profile of Punica granatum: an overview. Int Res J Pharm 3 (2012), 65–68.
10. Katz, S.R., Newman, R.A., Lansky, E.P., Punica granatum: heuristic treatment for diabetes mellitus. J Med Food 10 (2007), 213–217.
11. Bekir, J., Mars, M., Souchard, J.P., Bouajila, J., Assessment of antioxidant, anti-inflammatory, anti-cholinesterase and cytotoxic activities of pomegranate (Punica granatum) leaves. Food Chem Toxicol 55 (2013), 470–475.
12. Amjad, L., Shafighi, M., Antioxidant activity of leaf different extracts in Punica granatum. Int J Biol Med Res 3 (2012), 2065–2067.
13. Das, S., Barman, S., Antidiabetic and antihyperlipidemic effects of ethanolic extract of leaves of Punica granatum in alloxan-induced non-insulin-dependent diabetes mellitus albino rats. Indian J Pharmacol 44 (2012), 219–224.
14. Adnyana, I.K., Sukandar, E.Y., Yuniarto, A., Finna, S., Anti-obesity effect of the pomegranate leaves ethanol extract (Punica granatum L.) in high fat diet induced mice. Int J Pharm Pharm Sci 6 (2014), 626–631.
15. Wagner, H., Bladt, S., Plant Drug Analysis. A Thin Layer Chromatography Atlas. 2nd ed., 1996, Springer, Berlin/New York.
16. Hajimahmoodi, M., Moghaddam, G., Ranjbar, A.M., et al. Total phenolic, flavonoids, tannin content and antioxidant power of some Iranian pomegranate flower cultivars (Punica granatum L.). Am J Plant Sci 4 (2013), 1815–1820.
17. Wu, K.K., Huan, Y., Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 40 (2008), 1–14, 10.1002/0471141755.ph0547s40 [Chapter: 5, Unit: 5.47].
18. Bhanoji Rao, M.E., Dama, G.Y., Evaluation of hepatoprotective activity of Punica granatum leaves on carbon tetrachloride induced hepatotoxicity in rats. Int J Univers Pharm Life Sci 1 (2011), 23–36.
19. Nishi, Ahad A., Kumar, P., Protective effect of chlorogenic acid against diabetic nephropathy in high fat diet/streptozotocin induced type-2 diabetic rats. Int J Pharm Pharm Sci 5 (2013), 489–495.
20. Halliwell, B., Chirico, S., Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nutr 57 (1993), 715S–724S.
21. Bastaki, S., Diabetes mellitus and its treatment. Int J Diabetes Metab 13 (2005), 111–134.
22. Wang, G.G., Lu, X.H., Li, W., Zhao, X., Zhang, C., Protective effects of luteolin on diabetic nephropathy in STZ-induced diabetic rats. Evid Based Complement Alternat Med 2011 (2011), 1–7.
23. Al-Muammar, M.N., Khan, F., Obesity: the preventive role of the pomegranate (Punica granatum). Nutrition 28 (2012), 595–604.
24. Patel, A.N., Bandwane, D.D., Mhetre, N.K., Pomegranate (Punica granatum Linn.) leaves attenuate disturbed glucose homeostasis and hyperglycemia mediated hyperlipidemia and oxidative stress in streptozotocin induced diabetic rats. Eur J Integr Med 6 (2014), 307–321.
25. Zafar, M., Naqvi, S.N., Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol 28 (2010), 135–142.
26. Lenzen, S., The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 (2008), 216–226.
27. Shewamene, Z., Abdelwuhab, M., Birhanu, Z., Methanolic leaf extract of Otostegia integrifolia Benth reduces blood glucose levels in diabetic, glucose loaded and normal rodents. BMC Comp Alt Med 15 (2015), 1–7.
28. Cheng, D., Liang, B., Li, Y., Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats. Biomed Res Int 2013 (2013), 1–7.
29. Nesbitt, K.N., An overview of diabetic nephropathy. J Pharm Prac 17 (2004), 75–79.
30. Viswanathan, V., Snehalatha, C., Kumutha, R., Jayaraman, M., Ramachandran, A., Serum albumin levels in different stages of type 2 diabetic nephropathy patients. Indian J Nephrol 14 (2004), 89–92.
31. Sohn, E., Kim, J., Kim, C., et al. The extract of Litsea japonica reduced the development of diabetic nephropathy via the inhibition of advanced glycation end products accumulation in db/db mice. Evid Based Complement Alternat Med 2013 (2013), 1–9.
32. Niedowicz, D.M., Daleke, D.L., The role of oxidative stress in diabetic complications. Cell Biochem Biophys 43 (2005), 289–330.
33. King, G.L., Loeken, M.R., Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 122 (2004), 333–338.